The Novel, Clinical-Stage Soluble Guanylate Cyclase Activator BI 685509 Protects from Disease Progression in Models of Renal Injury and Disease
Glenn A. Reinhart, Paul C. Harrison, Kathleen Lincoln, Hongxing Chen, Peng Sun, Jon Hill, Hu Sheng Qian, Mark McHugh, Holly D. Clifford, Khing Jow Ng, Hong Wang, Danielle Fowler, Kristina Gueneva-Boucheva, Jehrod Brenneman, Todd Bosanac, Diane Wong, Ryan M. Fryer, Chris Sarko, Carine M. Boustany‐Kari, Steven S. Pullen
Topics & Concepts
Cyclic guanosine monophosphateEnalaprilGuanosine monophosphateNitric oxidePharmacologyMean arterial pressureInternal medicineEndocrinologyActivator (genetics)MedicineChemistrySoluble guanylyl cyclaseBlood pressureHeart rateAngiotensin-converting enzymeReceptorBiochemistryGuanylate cyclaseNucleotideGeneNitric Oxide and Endothelin EffectsRenin-Angiotensin System StudiesDialysis and Renal Disease Management